Cargando…
Risk for neonatal hypoglycaemia and bradycardia after beta-blocker use during pregnancy or lactation: a systematic review and meta-analysis protocol
INTRODUCTION: Beta-blockers are often used during pregnancy to treat diseases such as pre-existing hypertension, arrhythmias or pregnancy-related hypertension. Since beta-blockers are able to cross the placenta and can pass into breast milk, they could potentially harm the neonate. Known potential n...
Autores principales: | de Bruin, Rosalie, van Dalen, Sarah L, Franx, Shamaya J, Simons, Sinno HP, Flint, Robert B, van den Bosch, Gerbrich E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422831/ https://www.ncbi.nlm.nih.gov/pubmed/36008071 http://dx.doi.org/10.1136/bmjopen-2021-055292 |
Ejemplares similares
-
The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis
por: de Bruin, Rosalie, et al.
Publicado: (2022) -
Scoping review of evidence for managing postnatal hypoglycaemia
por: Horwitz, Jennifer, et al.
Publicado: (2022) -
Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial
por: Laing, Don, et al.
Publicado: (2022) -
Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-D—a study protocol of a prospective longitudinal study
por: Hoermann, Henrike, et al.
Publicado: (2022) -
COVID-19 lockdown impacts the wellbeing of parents with infants on a Dutch neonatal intensive care unit
por: Meesters, Naomi, et al.
Publicado: (2022)